logo

Johnson & Johnson begins Phase 3 COVID-19 vaccine candidate trial in SA

Johnson & Johnson’s Phase 3 trial of its COVID-19 vaccine candidate has commenced in South Africa. The first South African ENSEMBLE participants were dosed last week. The study is also on-going in the United States, Brazil, Chile, Colombia and Argentina. Ludovic de Beaucoudrey, the Medical Affairs Director at Janssen South Africa joins CNBC Africa for more.


Tue Nov 10 2020 | 17:55:49 GMT+0000 (Coordinated Universal Time)

Share

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.